Brightview LLC
Brightview LLC was paid $579K by Medicaid between Jul 2020 and Feb 2022, across 20 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
LONDON, KY 40741
Next to other Community/Behavioral Health Agency providers in Kentucky
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 201 | $5K | |
| 2021 | 15,758 | $558K | |
| 2022 | 430 | $15K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 5,991 | 3,258 | $208K |
| T2023 | Targeted case management; per month | 17% | 684 | 521 | $96K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 8.8% | 452 | 271 | $51K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 8.3% | 855 | 594 | $48K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 7.4% | 1,759 | 1,012 | $43K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6.7% | 1,511 | 849 | $39K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 4.3% | 291 | 210 | $25K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.4% | 787 | 486 | $19K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 2.2% | 365 | 309 | $13K |
| 99406 | 1.4% | 1,930 | 1,159 | $8K | |
| H0001 | Alcohol and/or drug assessment | 1.4% | 263 | 197 | $8K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 570 | 322 | $5K |
8 more codes
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 44 | $4K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 78 | $4K |
| H0038 | Self-help/peer services, per 15 minutes | <1% | 287 | $3K |
| 99205 | Prolong outpt/office vis | <1% | 31 | $2K |
| 81025 | <1% | 443 | $2K | |
| T1007 | Alcohol and/or substance abuse services, treatment plan development and/or modification | <1% | 15 | $492.61 |
| 82075 | <1% | 15 | $252.90 | |
| 80305 | <1% | 18 | $66.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Brightview, LLC | Cincinnati, OH | $501.08M |
| Column Health, LLC | Lawrence, MA | $32.69M |
| Brightview LLC | Lynchburg, VA | $31.97M |
| Brightview LLC | Nicholasville, KY | $11.47M |
| Chesapeake Treatment Services LLC | Easton, MD | $5.20M |
| Chesapeake Treatment Services Ocean City LLC | Ocean City, MD | $4.74M |
| Brightview LLC | Lexington, KY | $2.06M |
| Brightview LLC | Cincinnati, OH | $1.13M |
| Brightview LLC | Paris, KY | $1.03M |
| Brightview LLC | Asheboro, NC | $597K |
| Brightview LLC | Louisville, KY | $29K |
| Brightview LLC | Georgetown, KY | $14K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.